The landscape of managing diabetes is evolving with the arrival of skin-applied GLP-1 therapy. These convenient delivery systems offer a potentially less invasive alternative to injections for individuals living with diabetes 2. They deliver glucagon-like peptide-1 directly through the epidermis, bypassing the requirement for daily injections an… Read More